Multicenter randomized placebo-controlled trials will evaluate the ability of the cytomegalovirus vaccine to enhance protective virus-specific immunity in stem cell donors to reduce the risk of CMV. | June 15, 2023
Fortress expects to file a total of three new drug applications in 2023 Record consolidated net revenue of $75.7 million for full-year 2022 FDA accepted.
Fortress expects to file a total of three new drug applications in 2023 Record consolidated net revenue of $75.7 million for full-year 2022 FDA accepted for filing the Biologics License Application. | March 30, 2023
MIAMI, March 07, 2023 Fortress Biotech, Inc. , an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic. | March 7, 2023
Avenue Therapeutics (ATXI) Enters into License Agreement with AnnJi Pharmaceutical to Develop and Commercialize AJ201 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.